Latest Casdin Capital, LLC Stock Portfolio
$1.02Billion
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Casdin Capital, LLC and it’s 13F Hedge Fund Stock Holdings
Casdin Capital, LLC is a hedge fund based in New York, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.7 Billions. In it's latest 13F Holdings report, Casdin Capital, LLC reported an equity portfolio of $903.5 Millions as of 30 Sep, 2023.
The top stock holdings of Casdin Capital, LLC are SRPT, BLFS, EQRX. The fund has invested 13.6% of it's portfolio in SAREPTA THERAPEUTICS INC and 11.9% of portfolio in BIOLIFE SOLUTIONS INC.
The fund managers got completely rid off CATALENT INC (CTLT), TWIST BIOSCIENCE CORP (TWST) and INCYTE CORP (INCY) stocks. They significantly reduced their stock positions in ILLUMINA INC (ILMN), MAXCYTE INC (MXCT) and BLUEPRINT MEDICINES CORP (BPMC). Casdin Capital, LLC opened new stock positions in PACIFIC BIOSCIENCES CALIF IN (PACB) and CODEXIS INC (CDXS). The fund showed a lot of confidence in some stocks as they added substantially to MIRATI THERAPEUTICS INC (MRTX), AVIDITY BIOSCIENCES INC (RNA) and TANGO THERAPEUTICS INC (TNGX).
The top stock holdings of Casdin Capital, LLC are SRPT, BLFS, EQRX. The fund has invested 13.6% of it's portfolio in SAREPTA THERAPEUTICS INC and 11.9% of portfolio in BIOLIFE SOLUTIONS INC.
The fund managers got completely rid off CATALENT INC (CTLT), TWIST BIOSCIENCE CORP (TWST) and INCYTE CORP (INCY) stocks. They significantly reduced their stock positions in ILLUMINA INC (ILMN), MAXCYTE INC (MXCT) and BLUEPRINT MEDICINES CORP (BPMC). Casdin Capital, LLC opened new stock positions in PACIFIC BIOSCIENCES CALIF IN (PACB) and CODEXIS INC (CDXS). The fund showed a lot of confidence in some stocks as they added substantially to MIRATI THERAPEUTICS INC (MRTX), AVIDITY BIOSCIENCES INC (RNA) and TANGO THERAPEUTICS INC (TNGX).
New Buys
| Ticker | $ Bought |
|---|---|
| NEUROGENE INC | 10,167,100 |
| SYNDAX PHARMACEUTICALS INC | 3,241,500 |
New stocks bought by Casdin Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ILLUMINA INC | 1,152 |
| CODEXIS INC | 566 |
| REVOLUTION MEDICINES INC | 215 |
| INTELLIA THERAPEUTICS INC | 23.08 |
| BIOLIFE SOLUTIONS INC | 11.92 |
| RELAY THERAPEUTICS INC | 6.71 |
| VERVE THERAPEUTICS INC | 1.84 |
Additions to existing portfolio by Casdin Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| 2SEVENTY BIO INC | -41.57 |
| STRUCTURE THERAPEUTICS INC | -13.22 |
| BLUEPRINT MEDICINES CORP | -12.12 |
| TANGO THERAPEUTICS INC | -9.1 |
| EXACT SCIENCES CORP | -8.59 |
| BEAM THERAPEUTICS INC | -7.37 |
| AVIDITY BIOSCIENCES INC | -5.94 |
| ALNYLAM PHARMACEUTICALS INC | -2.5 |
Casdin Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| EQRX INC | -87,751,400 |
| MAXCYTE INC | -5,896,800 |
| SANA BIOTECHNOLOGY INC | -2,902,500 |
| MIRATI THERAPEUTICS INC | -21,711,500 |
Casdin Capital, LLC got rid off the above stocks
Current Stock Holdings of Casdin Capital, LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ABCL | ABCELLERA BIOLOGICS INC | 1.32 | 2,360,130 | 13,476,300 | UNCHANGED | 0.00 | |
| ABSI | ABSCI CORPORATION | 0.40 | 973,260 | 4,087,690 | UNCHANGED | 0.00 | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 3.66 | 195,000 | 37,325,000 | REDUCED | -2.5 | |
| BEAM | BEAM THERAPEUTICS INC | 1.41 | 528,000 | 14,372,200 | REDUCED | -7.37 | |
| BLFS | BIOLIFE SOLUTIONS INC | 13.89 | 8,707,160 | 141,491,000 | ADDED | 11.92 | |
| BPMC | BLUEPRINT MEDICINES CORP | 2.96 | 326,378 | 30,105,100 | REDUCED | -12.12 | |
| CDXS | CODEXIS INC | 0.60 | 2,000,000 | 6,100,000 | ADDED | 566 | |
| DNLI | DENALI THERAPEUTICS INC | 2.74 | 1,300,000 | 27,898,000 | UNCHANGED | 0.00 | |
| EQRX | EQRX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| EXAI | EXSCIENTIA PLC | 0.14 | 213,900 | 1,371,100 | UNCHANGED | 0.00 | |
| EXAS | EXACT SCIENCES CORP | 3.05 | 420,000 | 31,071,600 | REDUCED | -8.59 | |
| FATE | FATE THERAPEUTICS INC | 0.75 | 2,050,000 | 7,667,000 | UNCHANGED | 0.00 | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2.06 | 1,033,810 | 20,945,000 | UNCHANGED | 0.00 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.28 | 510,882 | 2,886,480 | UNCHANGED | 0.00 | |
| ILMN | ILLUMINA INC | 4.28 | 313,000 | 43,582,100 | ADDED | 1,152 | |
| IPSC | CENTURY THERAPEUTICS INC | 1.04 | 3,206,380 | 10,645,200 | UNCHANGED | 0.00 | |
| KRON | KRONOS BIO INC | 0.01 | 123,839 | 154,799 | UNCHANGED | 0.00 | |
| LAB | STANDARD BIOTOOLS INC | 0.26 | 1,200,000 | 2,652,000 | UNCHANGED | 0.00 | |
| LIAN | LIANBIO | 0.09 | 206,415 | 922,675 | UNCHANGED | 0.00 | |
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MXCT | MAXCYTE INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NTLA | INTELLIA THERAPEUTICS INC | 4.34 | 1,450,000 | 44,210,500 | ADDED | 23.08 | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | 0.06 | 1,323,880 | 609,119 | UNCHANGED | 0.00 | |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1.00 | 1,035,860 | 10,161,800 | UNCHANGED | 0.00 | |
| PLRX | PLIANT THERAPEUTICS INC | 2.80 | 1,577,110 | 28,561,400 | UNCHANGED | 0.00 | |
| RLAY | RELAY THERAPEUTICS INC | 7.98 | 7,387,940 | 81,341,200 | ADDED | 6.71 | |
| RNA | AVIDITY BIOSCIENCES INC | 1.04 | 1,175,750 | 10,640,500 | REDUCED | -5.94 | |
| RVMD | REVOLUTION MEDICINES INC | 16.09 | 5,714,780 | 163,900,000 | ADDED | 215 | |
| SANA | SANA BIOTECHNOLOGY INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SLGC | SOMALOGIC INC | 3.13 | 12,604,300 | 31,888,800 | UNCHANGED | 0.00 | |
| SMFR | GENEDX HOLDINGS CORP | 0.84 | 3,095,510 | 8,512,660 | UNCHANGED | 0.00 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.32 | 150,000 | 3,241,500 | NEW | ||
| SRPT | SAREPTA THERAPEUTICS INC | 9.53 | 1,006,500 | 97,056,800 | REDUCED | -0.38 | |
| TNGX | TANGO THERAPEUTICS INC | 1.16 | 1,188,350 | 11,764,700 | REDUCED | -9.1 | |
| TNYA | TENAYA THERAPEUTICS INC | 2.03 | 6,381,380 | 20,675,700 | UNCHANGED | 0.00 | |
| TSVT | 2SEVENTY BIO INC | 0.50 | 1,182,620 | 5,049,800 | REDUCED | -41.57 | |
| VERV | VERVE THERAPEUTICS INC | 4.12 | 3,009,090 | 41,946,800 | ADDED | 1.84 | |
| STRUCTURE THERAPEUTICS INC | 4.37 | 1,091,870 | 44,504,500 | REDUCED | -13.22 | ||
| NEUROGENE INC | 1.00 | 524,616 | 10,167,100 | NEW | |||
| PRIME MEDICINE INC | 0.32 | 367,175 | 3,253,170 | UNCHANGED | 0.00 |